-
Mashup Score: 0Pivotal CV Trials May Not Apply to Complex Patients - 1 year(s) ago
John Mandrola, MD, interviews Andrew Foy, MD, about his meta-analysis of major cardiovascular trials looking at patients with higher comorbidity burden to see if they experience treatment benefits.
Source: MedscapeCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 0
There was a case of phrenic nerve palsy, which raises a small red flag and will need to be watched in future studies, say experts.
Source: TCTMD.comCategories: Cardiology News and Journals, Latest HeadlinesTweet-
Research at #ACC23/#WCCardio found that use of the PulseSelect ablation system safely & effectively decreased atrial arrhythmia recurrence in patients with paroxysmal #AFib. @michaelTCTMD discusses the latest research on #epAblation in @TCTMD: https://t.co/zTbsA2MTrF
-
-
Mashup Score: 0Understanding INOCA and MINOCA epidemiology - 1 year(s) ago
Janet Wei, MD, associate medical director of the Biomedical Imaging Research Institute, and co-director of the stress echocardiography lab at Cedars-Sinai Hospital, explains the current information on the INOCA and MINOCA.
Source: Cardiovascular BusinessCategories: Cardiology News and Journals, Latest HeadlinesTweet-
Janet Wei, MD, Cedars-Sinai Hospital, explains the current information on the INOCA and MINOCA. #womenshealth @CedarsSinai #ACC23 #cardiology #cardiotwitter #INOCA #MINOCA #SCAD https://t.co/w7LXRsB3lC
-
-
Mashup Score: 2Advancing the field: Sports cardiology, hypertrophic cardiomyopathy highlighted at ACC.23 - 1 year(s) ago
Cardiology Today | The American College of Cardiology Scientific Session featured three late-breaking clinical trials of particular interest to the sports cardiology and hypertrophic cardiomyopathy communities. In this column, we provide highlights and clinical implications from those trials, plus two additional sports cardiology sessions.
Source: www.healio.comCategories: Cardiology News and Journals, Latest HeadlinesTweet-
A presentation at #ACC23 "provides further evidence against universal restriction of vigorous exercise in HCM patients" https://t.co/9tibSRQna2 @BradLander18 @RobynBrydeMD @mmartinezheart @AtlanticHealth #CardioTwitter #Cardiology #sportscardiology @ACCmediacenter @ACCinTouch
-
-
Mashup Score: 0Racial Disparities in Cardiotoxicity After Chemotherapy - 1 year(s) ago
Black patients with cancer are significantly more likely to experience heart damage following chemotherapy than White patients are, a research review indicates.
Source: MedscapeCategories: General Medicine News, Latest HeadlinesTweet-
A research review shows Black cancer patients are more likely to experience cardiotoxicity and congestive heart failure related to chemotherapy. https://t.co/k6OtbHImsI #MedTwitter #ACC23 #WCCardio
-
-
Mashup Score: 1ACC Anywhere - Landing page - 1 year(s) ago
ACC Anywhere provides easy access to all of ACC’s video content in one location. You can easily search and browse presentations and watch Collections anytime, anywhere with on demand access. Collection ACCSAP Session Featuring This Year’s CMP Topic Part 1: Test Yourself With Questions on Valvular Heart Disease ACCSAP Session Featuring This Year’s CMP Topic Part 1: Test Yourself With Questions…
Source: accanywhere.acc.orgCategories: Cardiology News and Journals, Latest HeadlinesTweet-
Get on-demand access to #ACC23/#WCCardio's Stump the Chump session where some of the best minds in pediatric & #CHD battle over the toughest congenital case. Hear their thought processes, how they use available data, & more w/ ACC Anywhere. 🔎 https://t.co/MF5pm2jR48 https://t.co/T89qT3DKQj
-
-
Mashup Score: 0Clues to How SGLT2 Inhibitors Work: CAMEO-DAPA - 1 year(s) ago
Ileana Piña, MD, MPH, and Barry A. Borlaug, MD, discuss the CAMEO-DAPA study in patients with HFpEF and potential mechanisms of action for SGLT2 inhibitors.
Source: MedscapeCategories: General Medicine News, Latest HeadlinesTweet-
Ileana Piña, MD, MPH, and Barry A. Borlaug, MD, discuss the CAMEO-DAPA study in patients with HFpEF and potential mechanisms of action for SGLT2 inhibitors. #ACC23 #WCCardio https://t.co/AAHGveWuh4
-
-
Mashup Score: 2Quality of Care and Outcomes Among Patients Hospitalized for Heart Failure in Rural vs Urban US Hospitals - 1 year(s) ago
This cohort study assesses quality of care and clinical outcomes for US patients hospitalized for heart failure at rural vs urban hospitals in the Get With The Guidelines–Heart Failure registry.
Source: jamanetwork.comCategories: Cardiology News and Journals, Latest HeadlinesTweet-
In this cohort study from @AHA_Research #GWTG_HF, patients hospitalized for #HF at rural hospitals are less likely to receive guideline therapies, but have similar in-hospital and 30-day outcomes. https://t.co/ryT3KctJxr @SJGreene_md @DCRINews #ACC23 #WCCardio
-
-
Mashup Score: 4
This case report describes a patient in their 60s with shortness of breath who tested positive for COVID-19.
Source: jamanetwork.comCategories: General Medicine Journals and Societies, Latest HeadlinesTweet-
This case report describes a patient in their 60s with shortness of breath who tested positive for COVID-19. #ACC23 #WCCardio https://t.co/IviZCrk39g
-
-
Mashup Score: 6Page Not Found - American College of Cardiology - 1 year(s) ago
ACC Member Care is available to assist you with any questions you may have when using ACC.org. Representatives are available Monday-Friday, 9:00 a.m.-5:00 p.m. (Eastern Time). You can reach the ACC Member Care Team by phone at 800-253-4636 (Toll Free US & Canada); 202-375-6000 (Outside US & Canada); Fax: 202-375-7000; or by Email at membercare@acc.org ACC Member Care The American College of…
Source: American College of CardiologyCategories: Cardiologists, Latest HeadlinesTweet-
Thanks to all @ACCinTouch members who generated interesting discussions around #ACC23 #LBCT on #DocMatter! #RenovateComplexPCI #TRILUMINATE & more.. #ACCIC #ACCEarlyCareer #ACCFIT If u haven’t used it yet, u can check out #DocMatter here: https://t.co/MEw45wqINx… https://t.co/aPX1wEoDfp
-
.@drjohnm interviews @AndrewFoy82 about his meta-analysis of major cardiovascular trials looking at patients with higher comorbidity burden to see if they experience treatment benefits. #ACC23 #WCCardio #CardioTwitter https://t.co/93prjzUaLP